Factors of importance for the subjective and objective burden of informal caregivers to patients with functional psychoses - a descriptive and comparative study
Study identifier:NIS-NSE-DUM-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Factors of importance for the subjective and objective burden of informal caregivers to patients with functional psychoses – a descriptive and comparative study
Medical condition
functional psychoses
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
100
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Mar 2008
Primary Completion Date: -
Study Completion Date: 01 Nov 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients having the following diagnoses are eligible for inclusion into the study: schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, delusional disorder, affective psychosis with mood incongruent delusions, psychotic disorder not otherwise specified or patients being actively psychotic. | - |
| 2 Closest relative(s) /informal caregiver(s) | - |
Contacts
Investigators
Principal Investigator
Eva Dencker Vansvik
AstraZeneca, MC, Sweden
